Bulgaria’s Biovet 9-mo non-cons net profit rises sharply

Biovet’s sales revenue rose to 128 million levs in the January-September period from 87.1 million levs a year earlier, the company said in a statement filed with the Bulgarian Stock Exchange (BSE) earlier this week.

Net earnings per share rose to 0.92 levs in the period under review from 0.28 levs in the first nine months of 2011.

(1 euro = 1.95583 Bulgarian levs)